Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: Marty R who wrote (2977)	4/2/2000 3:15:00 AM
From: misti30	Read Replies (1) \| Respond to of 5665

I second the thanks. Bob and Gary.. You guys seem to be very knowledgeable on this subject.. A special thanks to n2health for the text of Mitch's presentation.. Mitch is so upbeat - like he's dying to tell us something. My concern has always been immunogenicity. I didn't know what to call it, but we know the sophistication of the human immune system is why we're still here.. Beyond that, from his comment, can we infer any evidence of efficacy? With these results.. with this potential.. why is ImmunoGen being ignored by the press, and the market?? I am not overly bothered by this. I think their (our) time will come. But I don't understand the silence.. Any average investor, knowing only what I know, would have ImmunoGen in her portfolio. Am I expecting too much? or is this a typical clinical trial process? misti